Who Paid My Doc
Ngam-12
Research payments
$347,062
Through program year 2023, $347,062 in research payments was reported against Ngam-12, across 115 payments, paid by Octapharma USA, Inc..
- Paid by
- Octapharma USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $5,650 | 34 |
| 2022 | Research | $248,680 | 71 |
| 2021 | Research | $92,732 | 10 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Wei Ding Rochester, MN Named on 13 payments
- Anthony Mato Philadelphia, PA Named on 12 payments
- Nicole Lamanna New York, NY Named on 10 payments
- Andrea Sitlinger Durham, NC Named on 7 payments
- Genovefa Papanicolaou New York, NY Named on 6 payments
- Pratibha Desai Saint Petersburg, FL Named on 5 payments
- Seung Tae Lee Baltimore, MD Named on 3 payments
- Luis Ostrosky Houston, TX Named on 2 payments
- Daniel Lebovic Grosse Pointe Woods, MI Named on 1 payment
- Lindsey Roeker New York, NY Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.